Bandingkan Harga & Kinerja CSIS WARRANT SERIES I (CSIS-W) vs UBC Medical Indonesia Tbk. (LABS)

CSIS WARRANT SERIES ITrading

UBC Medical Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan CSIS WARRANT SERIES I dan UBC Medical Indonesia Tbk.: CSIS WARRANT SERIES I diperdagangkan di Rp88 (kapitalisasi pasar 4,34 M, volume 24 jam 16,1 rb), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 817,3 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 134,7× kapitalisasi pasar CSIS WARRANT SERIES I, dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (817,3 rb vs 16,1 rb). Mana yang lebih baik tergantung tujuan investasimu.

	CSIS-W	LABS
Kapitalisasi Pasar	4,34 M	584,6 M
Volume	16,1 rb	817,3 rb
Lot	161	8,17 rb
Perputaran	1,31 jt	120,01 jt
Harga Rata-rata	81,55	146,84
Nilai Transaksi	1,31 jt	120,01 jt
Harga Ekuilibrium Indikatif	88	146
Volume Ekuilibrium Indikatif	1	59

Lihat detail →Lihat detail →

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

CSIS-W

Lihat detail →

LABS

Lihat detail →

Tentang CSIS WARRANT SERIES I

PT Cahayasakti Investindo Sukses Tbk (the Company) was established based on the Deed of Notary Djurnawati Soetarmono, SH, No. 52 dated June 2, 1995. The Company belongs to a group of companies owned by PT Andalan Utama Bintara.

Selengkapnya di halaman CSIS-W →

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS →